[Ulcerative colitis and Crohn's disease].
Matsuoka
Katsuyoshi
K
Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Keio University.
Hibi
Toshifumi
T
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood; D000908:Antibodies, Fungal / Q000097:blood; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001062:Appendectomy; D015415:Biomarkers / Q000097:blood; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D003424:Crohn Disease / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D007422:Intestines / Q000382:microbiology; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000502:physiology; D019804:Mesalamine / Q000627:therapeutic use; D009154:Mutation; D053473:Nod2 Signaling Adaptor Protein; D019936:Probiotics / Q000627:therapeutic use; D012441:Saccharomyces cerevisiae / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000900:Anti-Bacterial Agents; D019268:Antibodies, Antineutrophil Cytoplasmic; D000908:Antibodies, Fungal; D000911:Antibodies, Monoclonal; D015415:Biomarkers; D007166:Immunosuppressive Agents; D047908:Intracellular Signaling Peptides and Proteins; C429018:NOD2 protein, human; D053473:Nod2 Signaling Adaptor Protein; D014409:Tumor Necrosis Factor-alpha; D019804:Mesalamine; D000069285:Infliximab